Calcium channel blocker induced gum hypertrophy: no class distinction
The blood pressure continued to be poorly controlled despite the use of six different antihypertensive drug classes (β blocker, α blocker, angiotensin II receptor blocker, potassium sparing diuretic as well as a loop diuretic, and a centrally acting agent).
Gespeichert in:
| Veröffentlicht in: | British heart journal 2004-01, Vol.90 (1), p.16-16 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 16 |
|---|---|
| container_issue | 1 |
| container_start_page | 16 |
| container_title | British heart journal |
| container_volume | 90 |
| creator | Samarasinghe, Y P Cox, A Feher, M D |
| description | The blood pressure continued to be poorly controlled despite the use of six different antihypertensive drug classes (β blocker, α blocker, angiotensin II receptor blocker, potassium sparing diuretic as well as a loop diuretic, and a centrally acting agent). |
| doi_str_mv | 10.1136/heart.90.1.16 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1768009</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4020642091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3596-c90e3e2b0cab8908ea38b1bbcfc354fb15736e6ffc665627b097f7606b67a4a73</originalsourceid><addsrcrecordid>eNqFkEtP3DAUhS1UBBS67BZFqpC6yWCPk-uYRaVqxBTEc0EfO8v2OMRDxh7sBDH_voaJeKxY3Xt1Pp17dBD6SvCIEAqHjZGhG_F0jQhsoB1SQJWPMfn3Ke20LHPAlG2jzzHOMcYFr2ALbSeIwZjiHXQ8ka22_SLTjXTOtJlqvb4zIbNu1mszy26T1qyWJnTBL5vVUeZ8plsZYzazsbNOd9a7PbRZyzaaL8PcRb-nxzeTk_z86tfp5Od5rmjJIdccG2rGCmupKo4rI2mliFK61rQsakVKRsFAXWuAEsZMYc5qBhgUMFlIRnfRj7XvslcLM9PGdUG2YhnsQoaV8NKK94qzjbj1D4IwqDDmyeDbYBD8fW9iJ-a-Dy5lTkiFoaCc0kTla0oHH2Mw9csHgsVT6-K5dcHTJQgkfv9trFd6qDkBBwMgo5ZtHaTTNr5yJeUFfY43PE7VmscXXYY7AYyyUlz-mYi_J9fVdFpciLPEf1_zajH_ION_zOqo8g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780643933</pqid></control><display><type>article</type><title>Calcium channel blocker induced gum hypertrophy: no class distinction</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Samarasinghe, Y P ; Cox, A ; Feher, M D</creator><creatorcontrib>Samarasinghe, Y P ; Cox, A ; Feher, M D</creatorcontrib><description>The blood pressure continued to be poorly controlled despite the use of six different antihypertensive drug classes (β blocker, α blocker, angiotensin II receptor blocker, potassium sparing diuretic as well as a loop diuretic, and a centrally acting agent).</description><identifier>ISSN: 1355-6037</identifier><identifier>ISSN: 0007-0769</identifier><identifier>EISSN: 1468-201X</identifier><identifier>DOI: 10.1136/heart.90.1.16</identifier><identifier>PMID: 14676230</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Cardiovascular Society</publisher><subject>Amlodipine - adverse effects ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Calcium ; Calcium Channel Blockers - adverse effects ; Cardiology. Vascular system ; Diuretics ; Gingival Hypertrophy - chemically induced ; Humans ; Hypertension ; Hypertension - drug therapy ; Images in cardiology ; Male ; Medical sciences ; Middle Aged ; Miscellanea</subject><ispartof>British heart journal, 2004-01, Vol.90 (1), p.16-16</ispartof><rights>Copyright 2004 by Heart</rights><rights>2004 INIST-CNRS</rights><rights>Copyright: 2004 Copyright 2004 by Heart</rights><rights>Copyright © Copyright 2004 by Heart 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3596-c90e3e2b0cab8908ea38b1bbcfc354fb15736e6ffc665627b097f7606b67a4a73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1768009/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1768009/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15394309$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14676230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samarasinghe, Y P</creatorcontrib><creatorcontrib>Cox, A</creatorcontrib><creatorcontrib>Feher, M D</creatorcontrib><title>Calcium channel blocker induced gum hypertrophy: no class distinction</title><title>British heart journal</title><addtitle>Heart</addtitle><description>The blood pressure continued to be poorly controlled despite the use of six different antihypertensive drug classes (β blocker, α blocker, angiotensin II receptor blocker, potassium sparing diuretic as well as a loop diuretic, and a centrally acting agent).</description><subject>Amlodipine - adverse effects</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Calcium</subject><subject>Calcium Channel Blockers - adverse effects</subject><subject>Cardiology. Vascular system</subject><subject>Diuretics</subject><subject>Gingival Hypertrophy - chemically induced</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Images in cardiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellanea</subject><issn>1355-6037</issn><issn>0007-0769</issn><issn>1468-201X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkEtP3DAUhS1UBBS67BZFqpC6yWCPk-uYRaVqxBTEc0EfO8v2OMRDxh7sBDH_voaJeKxY3Xt1Pp17dBD6SvCIEAqHjZGhG_F0jQhsoB1SQJWPMfn3Ke20LHPAlG2jzzHOMcYFr2ALbSeIwZjiHXQ8ka22_SLTjXTOtJlqvb4zIbNu1mszy26T1qyWJnTBL5vVUeZ8plsZYzazsbNOd9a7PbRZyzaaL8PcRb-nxzeTk_z86tfp5Od5rmjJIdccG2rGCmupKo4rI2mliFK61rQsakVKRsFAXWuAEsZMYc5qBhgUMFlIRnfRj7XvslcLM9PGdUG2YhnsQoaV8NKK94qzjbj1D4IwqDDmyeDbYBD8fW9iJ-a-Dy5lTkiFoaCc0kTla0oHH2Mw9csHgsVT6-K5dcHTJQgkfv9trFd6qDkBBwMgo5ZtHaTTNr5yJeUFfY43PE7VmscXXYY7AYyyUlz-mYi_J9fVdFpciLPEf1_zajH_ION_zOqo8g</recordid><startdate>200401</startdate><enddate>200401</enddate><creator>Samarasinghe, Y P</creator><creator>Cox, A</creator><creator>Feher, M D</creator><general>BMJ Publishing Group Ltd and British Cardiovascular Society</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>Copyright 2004 by Heart</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>200401</creationdate><title>Calcium channel blocker induced gum hypertrophy: no class distinction</title><author>Samarasinghe, Y P ; Cox, A ; Feher, M D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3596-c90e3e2b0cab8908ea38b1bbcfc354fb15736e6ffc665627b097f7606b67a4a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Amlodipine - adverse effects</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Calcium</topic><topic>Calcium Channel Blockers - adverse effects</topic><topic>Cardiology. Vascular system</topic><topic>Diuretics</topic><topic>Gingival Hypertrophy - chemically induced</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Images in cardiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellanea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samarasinghe, Y P</creatorcontrib><creatorcontrib>Cox, A</creatorcontrib><creatorcontrib>Feher, M D</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samarasinghe, Y P</au><au>Cox, A</au><au>Feher, M D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcium channel blocker induced gum hypertrophy: no class distinction</atitle><jtitle>British heart journal</jtitle><addtitle>Heart</addtitle><date>2004-01</date><risdate>2004</risdate><volume>90</volume><issue>1</issue><spage>16</spage><epage>16</epage><pages>16-16</pages><issn>1355-6037</issn><issn>0007-0769</issn><eissn>1468-201X</eissn><abstract>The blood pressure continued to be poorly controlled despite the use of six different antihypertensive drug classes (β blocker, α blocker, angiotensin II receptor blocker, potassium sparing diuretic as well as a loop diuretic, and a centrally acting agent).</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Cardiovascular Society</pub><pmid>14676230</pmid><doi>10.1136/heart.90.1.16</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1355-6037 |
| ispartof | British heart journal, 2004-01, Vol.90 (1), p.16-16 |
| issn | 1355-6037 0007-0769 1468-201X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1768009 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Amlodipine - adverse effects Antihypertensive Agents - therapeutic use Biological and medical sciences Calcium Calcium Channel Blockers - adverse effects Cardiology. Vascular system Diuretics Gingival Hypertrophy - chemically induced Humans Hypertension Hypertension - drug therapy Images in cardiology Male Medical sciences Middle Aged Miscellanea |
| title | Calcium channel blocker induced gum hypertrophy: no class distinction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T23%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcium%20channel%20blocker%20induced%20gum%20hypertrophy:%20no%20class%20distinction&rft.jtitle=British%20heart%20journal&rft.au=Samarasinghe,%20Y%20P&rft.date=2004-01&rft.volume=90&rft.issue=1&rft.spage=16&rft.epage=16&rft.pages=16-16&rft.issn=1355-6037&rft.eissn=1468-201X&rft_id=info:doi/10.1136/heart.90.1.16&rft_dat=%3Cproquest_pubme%3E4020642091%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780643933&rft_id=info:pmid/14676230&rfr_iscdi=true |